Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1368
| Despition | KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
| ACPP-1625 | Human POMC Protein (AC1625) | 2 µg | inquiry |
| ACPP-1454 | Human PICK1 Protein (AC1454) | 2 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1310 | SHC Blocking Peptide (AC1310) | 250 µg | inquiry |
| ACPP-1620 | Human SIX6 Protein (AC1620) | 5 µg | inquiry |
| ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg | inquiry |
| ACPP-1268 | Human LGALS3 Protein (AC1268) | 10 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1624 | Human EFNA1 Protein (AC1624) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.